Devices for Dry Powder Drug Delivery to the Lung

• Published in: AAPS PharmSciTech Vol. 16; no. 3; pp. 479 - 490
• Main Authors: Berkenfeld, Kai, Lamprecht, Alf, McConville, Jason T.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.06.2015
• Subjects: Administration, Inhalation; Biochemistry; Biomedical and Life Sciences; Biomedicine; Biotechnology; Drug Delivery Systems - instrumentation; Dry Powder Inhalers - instrumentation; Equipment Design - instrumentation; Humans; Lung - drug effects; Pharmaceutical Preparations - administration & dosage; Pharmacology/Toxicology; Pharmacy; Powders - administration & dosage; Reproducibility of Results; Review; Review Article; Theme: Advances in Formulation and Device Technologies for Pulmonary Drug Delivery; dry powder inhaler; particle deagglomeration; disposable; vaccination
• ISSN: 1530-9932; 1530-9932
• DOI: 10.1208/s12249-015-0317-x

Dry powder inhalers (DPIs) are an important and increasingly investigated method of modern therapy for a growing number of respiratory diseases. DPIs are a promising option for certain patient populations, and may help to overcome several limitations that are associated with other types of inhalation delivery systems ( e.g. , accuracy and reproducibility of the dose delivered, compliance and adherence issues, or environmental aspects). Today, more than 20 different dry powder inhalers are on the market to deliver active pharmaceutical ingredients (APIs) for local and/or systemic therapy. Depending on the mechanism of deagglomeration, aerosolization, dose metering accuracy, and the interpatient variability, dry powder inhalers demonstrate varying performance levels. During development, manufacturers focus on improving aspects characteristic of their specific DPI devices, depending on the intended type of application and any particular requirements associated with it. With the wide variety of applications related to specific APIs, there exists a range of different devices with distinct features. In addition to the routinely used multi-use DPIs, several single-use disposable devices are under development or already approved. The recent introduction of disposable devices will expand the range of possible applications for use by including agents such as vaccines, analgesics, or even rescue medications. This review article discusses the performance and advantages of recently approved dry powder inhalers as well as disposable single-use inhalers that are currently under development.